The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 03, 2020

Filed:

Mar. 06, 2019
Applicant:

The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US);

Inventors:

Seung K. Kim, Stanford, CA (US);

Sangbin Park, Stanford, CA (US);

Ronald Alfa, Salt Lake City, UT (US);

Cecile Jacovetti, San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/26 (2006.01); G01N 33/74 (2006.01); G01N 33/68 (2006.01); G01N 33/564 (2006.01);
U.S. Cl.
CPC ...
C07K 16/26 (2013.01); G01N 33/564 (2013.01); G01N 33/6893 (2013.01); G01N 33/74 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); G01N 2333/575 (2013.01); G01N 2800/042 (2013.01); G01N 2800/067 (2013.01); G01N 2800/50 (2013.01);
Abstract

The inventors have produced two high specificity and high affinity monoclonal antibodies that bind to human neuromedin U (NMU). Methods and compositions are provided for treating an individual in need thereof (e.g., an individual who is obese and/or has diabetes) by administering an anti-NMU/NMUR agent (e.g., an anti-NMU antibody). For example, methods and compositions are provided for increasing circulating insulin in an individual. Methods and compositions are also provided for detecting neuromedin U (NMU) (e.g., in a biological sample such as serum). Methods and compositions are also provided for predicting whether an individual will develop diabetes and/or PDAC, and for identifying an individual who would benefit from administration of an anti-NMU/NMUR agent.


Find Patent Forward Citations

Loading…